EDEX Drug Patent Profile
✉ Email this page to a colleague
When do Edex patents expire, and what generic alternatives are available?
Edex is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in EDEX is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Edex
A generic version of EDEX was approved as alprostadil by HIKMA on January 20th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EDEX?
- What are the global sales for EDEX?
- What is Average Wholesale Price for EDEX?
Summary for EDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 4,231 |
Drug Prices: | Drug price information for EDEX |
What excipients (inactive ingredients) are in EDEX? | EDEX excipients list |
DailyMed Link: | EDEX at DailyMed |
Pharmacology for EDEX
Drug Class | Prostaglandin Analog Prostaglandin E1 Agonist |
Mechanism of Action | Prostaglandin Receptor Agonists |
Physiological Effect | Genitourinary Arterial Vasodilation Venous Vasodilation |
US Patents and Regulatory Information for EDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-001 | Jun 12, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-007 | Jul 30, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-003 | Jun 12, 1997 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-002 | Jun 12, 1997 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-005 | Jul 30, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-004 | Jun 12, 1997 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Endo Operations | EDEX | alprostadil | INJECTABLE;INJECTION | 020649-006 | Jul 30, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |